Global Kinase Inhibitors Market 2011-2015
Global Kinase Inhibitors Market
Description
TechNavio's analysts forecast the Global Kinase Inhibitor market to grow at a CAGR of 6.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the prevalence of disease. The Global Kinase Inhibitor market has also been witnessing the trend of an increase in the number of mergers and acquisitions. However, patent expiration of kinase inhibitors could pose a challenge to the growth of this market.
TechNavio's report, the Global Kinase Inhibitor Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Kinase Inhibitor market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are AstraZeneca plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Roche Holding Ltd.
The other vendors mentioned in the report are Takeda Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Eli Lilly and Co., Abbott Laboratories Inc., Amgen Inc., Bayer AG, Johnson & Johnson Ltd., Sanofi S.A., Eisai Inc., Bristol-Myers Squibb Co., Boehringer Ingelheim GmbH, Mylan Inc., Teva Pharmaceutical Industries Ltd., and Ranbaxy Laboratories Ltd.
Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
01. Executive Summary
02. Introduction
03. Market Coverage
Overview
Key Offerings
04. Market Landscape
04.1 Global Enzyme Inhibitors Market
04.2 Market Segmentation
04.3 Global Kinase Inhibitors Market
04.4 Five Forces Analysis
05. Geographical Segmentation
06. Vendor Landscape
Vendor Ranking
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
13.2 Merck and Co. Inc.
Business Overview
Key Information
SWOT Analysis
13.3 Novartis AG
Business Overview
Key Information
SWOT Analysis
13.4 Pfizer Inc.
Business Overview
Key Information
SWOT ANALYSIS
13.5 Roche Holdings Ltd.
Business Overview
Key Information
SWOT Analysis
Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Enzyme Inhibitors Market 20112015 (US$ billion)
Exhibit 2: Global Enzyme Inhibitors Market Segmentation
Exhibit 3: Global Enzyme Inhibitors Market Segmentation 2011
Exhibit 4: Global Enzyme Inhibitors Market 20112015 (US$ billion)
Exhibit 5: Global Kinase Inhibitors market by Geographical Segmentation 2011
Exhibit 6: Vendor Ranking in Global Kinase Inhibitor Market 2011
To Browse All Reports: http://www.marketresearchreports.biz/
Global Kinase Inhibitors Market
Description
TechNavio's analysts forecast the Global Kinase Inhibitor market to grow at a CAGR of 6.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the prevalence of disease. The Global Kinase Inhibitor market has also been witnessing the trend of an increase in the number of mergers and acquisitions. However, patent expiration of kinase inhibitors could pose a challenge to the growth of this market.
TechNavio's report, the Global Kinase Inhibitor Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Kinase Inhibitor market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are AstraZeneca plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Roche Holding Ltd.
The other vendors mentioned in the report are Takeda Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Eli Lilly and Co., Abbott Laboratories Inc., Amgen Inc., Bayer AG, Johnson & Johnson Ltd., Sanofi S.A., Eisai Inc., Bristol-Myers Squibb Co., Boehringer Ingelheim GmbH, Mylan Inc., Teva Pharmaceutical Industries Ltd., and Ranbaxy Laboratories Ltd.
Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
01. Executive Summary
02. Introduction
03. Market Coverage
Overview
Key Offerings
04. Market Landscape
04.1 Global Enzyme Inhibitors Market
04.2 Market Segmentation
04.3 Global Kinase Inhibitors Market
04.4 Five Forces Analysis
05. Geographical Segmentation
06. Vendor Landscape
Vendor Ranking
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
13.2 Merck and Co. Inc.
Business Overview
Key Information
SWOT Analysis
13.3 Novartis AG
Business Overview
Key Information
SWOT Analysis
13.4 Pfizer Inc.
Business Overview
Key Information
SWOT ANALYSIS
13.5 Roche Holdings Ltd.
Business Overview
Key Information
SWOT Analysis
Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Enzyme Inhibitors Market 20112015 (US$ billion)
Exhibit 2: Global Enzyme Inhibitors Market Segmentation
Exhibit 3: Global Enzyme Inhibitors Market Segmentation 2011
Exhibit 4: Global Enzyme Inhibitors Market 20112015 (US$ billion)
Exhibit 5: Global Kinase Inhibitors market by Geographical Segmentation 2011
Exhibit 6: Vendor Ranking in Global Kinase Inhibitor Market 2011
To Browse All Reports: http://www.marketresearchreports.biz/
No comments:
Post a Comment